These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12604046)

  • 1. Ligand-targeted liposomes directed against pathological vasculature.
    Schiffelers RM; Molema G; ten Hagen TL; Janssen AP; Schraa AJ; Kok RJ; Koning GA; Storm G
    J Liposome Res; 2002; 12(1-2):129-35. PubMed ID: 12604046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced active targeting via cooperative binding of ligands on liposomes to target receptors.
    Sugiyama T; Asai T; Nedachi YM; Katanasaka Y; Shimizu K; Maeda N; Oku N
    PLoS One; 2013; 8(6):e67550. PubMed ID: 23840738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
    Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q
    J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle.
    Mulder WJ; Strijkers GJ; Habets JW; Bleeker EJ; van der Schaft DW; Storm G; Koning GA; Griffioen AW; Nicolay K
    FASEB J; 2005 Dec; 19(14):2008-10. PubMed ID: 16204353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-targeted PEG-liposomes in anti-angiogenic therapy.
    Janssen AP; Schiffelers RM; ten Hagen TL; Koning GA; Schraa AJ; Kok RJ; Storm G; Molema G
    Int J Pharm; 2003 Mar; 254(1):55-8. PubMed ID: 12615409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new colloidal lipidic system for gene therapy.
    Fahr A; Müller K; Nahde T; Müller R; Brüsselbach S
    J Liposome Res; 2002; 12(1-2):37-44. PubMed ID: 12604036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of liposomes to angiogenic endothelial cells.
    Schiffelers RM; Molema G; Ten Hagen TL; Janssen AP; Schraa AJ; Kok RJ; Koning GA; Storm G
    Cell Mol Biol Lett; 2002; 7(2):255. PubMed ID: 12097939
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
    Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
    Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis.
    Koning GA; Schiffelers RM; Wauben MH; Kok RJ; Mastrobattista E; Molema G; ten Hagen TL; Storm G
    Arthritis Rheum; 2006 Apr; 54(4):1198-208. PubMed ID: 16575845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4.
    Ma L; Liu YL; Ma ZZ; Dou HL; Xu JH; Wang JC; Zhang X; Zhang Q
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):195-200. PubMed ID: 19456253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    Biomaterials; 2013 Jul; 34(22):5617-27. PubMed ID: 23623323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug.
    de Groot FM; Broxterman HJ; Adams HP; van Vliet A; Tesser GI; Elderkamp YW; Schraa AJ; Kok RJ; Molema G; Pinedo HM; Scheeren HW
    Mol Cancer Ther; 2002 Sep; 1(11):901-11. PubMed ID: 12481411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.
    Urbinati C; Mitola S; Tanghetti E; Kumar C; Waltenberger J; Ribatti D; Presta M; Rusnati M
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2315-20. PubMed ID: 16166568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes.
    van Tilborg GA; Mulder WJ; van der Schaft DW; Reutelingsperger CP; Griffioen AW; Strijkers GJ; Nicolay K
    Neoplasia; 2008 Dec; 10(12):1459-69. PubMed ID: 19048124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe.
    Mulder WJ; Koole R; Brandwijk RJ; Storm G; Chin PT; Strijkers GJ; de Mello Donegá C; Nicolay K; Griffioen AW
    Nano Lett; 2006 Jan; 6(1):1-6. PubMed ID: 16402777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD modified albumin nanospheres for tumour vasculature targeting.
    Dubey PK; Singodia D; Verma RK; Vyas SP
    J Pharm Pharmacol; 2011 Jan; 63(1):33-40. PubMed ID: 21155813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools.
    Bianchini F; De Santis A; Portioli E; Russo Krauss I; Battistini L; Curti C; Peppicelli S; Calorini L; D'Errico G; Zanardi F; Sartori A
    Nanomedicine; 2019 Jun; 18():135-145. PubMed ID: 30849548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.
    Schiffelers RM; Koning GA; ten Hagen TL; Fens MH; Schraa AJ; Janssen AP; Kok RJ; Molema G; Storm G
    J Control Release; 2003 Aug; 91(1-2):115-22. PubMed ID: 12932643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin Targeting and Toxicological Assessment of Peptide-Conjugated Liposome Delivery Systems to Activated Endothelial Cells.
    Kermanizadeh A; Villadsen K; Østrem RG; Jensen KJ; Møller P; Loft S
    Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):380-389. PubMed ID: 27767251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.